Nada H. Eisa

615 total citations
25 papers, 382 citations indexed

About

Nada H. Eisa is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Nada H. Eisa has authored 25 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in Nada H. Eisa's work include Chemotherapy-induced organ toxicity mitigation (3 papers), Vitamin D Research Studies (3 papers) and MicroRNA in disease regulation (3 papers). Nada H. Eisa is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (3 papers), Vitamin D Research Studies (3 papers) and MicroRNA in disease regulation (3 papers). Nada H. Eisa collaborates with scholars based in Egypt, United States and Saudi Arabia. Nada H. Eisa's co-authors include Mohamed El‐Sherbiny, Nehal M. Elsherbiny, Nada F. Abo El‐Magd, Eman Said, William Hill, Ahmed M. Elmansi, Mark W. Hamrick, Dmitry Kondrikov, Carlos M. Isales and Sadanand Fulzele and has published in prestigious journals such as Cancer Research, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Nada H. Eisa

23 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nada H. Eisa Egypt 13 164 54 53 51 48 25 382
Eslam E. Abd El-Fattah Egypt 14 256 1.6× 91 1.7× 29 0.5× 97 1.9× 39 0.8× 18 496
Brian K. Park United States 9 222 1.4× 47 0.9× 30 0.6× 41 0.8× 17 0.4× 14 552
Dejun Cui China 10 159 1.0× 55 1.0× 37 0.7× 53 1.0× 13 0.3× 35 369
Yi A. Ren China 12 261 1.6× 53 1.0× 43 0.8× 99 1.9× 14 0.3× 15 604
Bo Youn Choi South Korea 9 260 1.6× 36 0.7× 27 0.5× 40 0.8× 38 0.8× 15 436
Mahmoud E. Youssef Egypt 14 256 1.6× 64 1.2× 36 0.7× 53 1.0× 8 0.2× 26 517
Fanhua Meng China 11 132 0.8× 24 0.4× 32 0.6× 50 1.0× 12 0.3× 32 416
Luling He China 10 176 1.1× 21 0.4× 19 0.4× 86 1.7× 23 0.5× 17 357

Countries citing papers authored by Nada H. Eisa

Since Specialization
Citations

This map shows the geographic impact of Nada H. Eisa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nada H. Eisa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nada H. Eisa more than expected).

Fields of papers citing papers by Nada H. Eisa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nada H. Eisa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nada H. Eisa. The network helps show where Nada H. Eisa may publish in the future.

Co-authorship network of co-authors of Nada H. Eisa

This figure shows the co-authorship network connecting the top 25 collaborators of Nada H. Eisa. A scholar is included among the top collaborators of Nada H. Eisa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nada H. Eisa. Nada H. Eisa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Eisa, Nada H., et al.. (2024). Pramipexole protects against diabetic neuropathy: Effect on oxidative stress, TLR4/IRAK-1/TRAF-6/NF-κB and downstream inflammatory mediators. International Immunopharmacology. 128. 111514–111514. 9 indexed citations
3.
El‐Mesery, Mohamed, et al.. (2024). Carbenoxolone upregulates TRAIL\TRAILR2 expression and enhances the anti-neoplastic effect of doxorubicin in experimentally induced hepatocellular carcinoma in rats. Biochemical and Biophysical Research Communications. 741. 150876–150876.
4.
Eisa, Nada H., Vincent M. Crowley, Asif Elahi, et al.. (2023). Enniatin A inhibits the chaperone Hsp90 and unleashes the immune system against triple-negative breast cancer. iScience. 26(12). 108308–108308. 11 indexed citations
5.
Eisa, Nada H., Vincent M. Crowley, Asif Elahi, et al.. (2023). Abstract 2272: Targeting the chaperone Hsp90 to activate the immune system and eradicate the triple negative breast cancer. Cancer Research. 83(7_Supplement). 2272–2272. 1 indexed citations
6.
Elmansi, Ahmed M., Nada H. Eisa, Sudharsan Periyasamy‐Thandavan, et al.. (2022). DPP4-Truncated CXCL12 Alters CXCR4/ACKR3 Signaling, Osteogenic Cell Differentiation, Migration, and Senescence. ACS Pharmacology & Translational Science. 6(1). 22–39. 7 indexed citations
7.
Eisa, Nada H., Eman Said, Ahmed E. Khodir, et al.. (2022). Effect of Diacerein on HOTAIR/IL-6/STAT3, Wnt/β-Catenin and TLR-4/NF-κB/TNF-α axes in colon carcinogenesis. Environmental Toxicology and Pharmacology. 95. 103943–103943. 12 indexed citations
8.
Eisa, Nada H., Sergi Mas, Samuel Herberg, et al.. (2021). Age-associated changes in microRNAs affect the differentiation potential of human mesenchymal stem cells: Novel role of miR-29b-1-5p expression. Bone. 153. 116154–116154. 8 indexed citations
9.
El‐Sherbiny, Mohamed, Nada H. Eisa, Nada F. Abo El‐Magd, et al.. (2021). Anti-inflammatory/anti-apoptotic impact of betulin attenuates experimentally induced ulcerative colitis: An insight into TLR4/NF-kB/caspase signalling modulation. Environmental Toxicology and Pharmacology. 88. 103750–103750. 21 indexed citations
10.
Shaker, Mohamed E., Nada H. Eisa, Abdelaziz Elgaml, et al.. (2021). Ingestion of mannose ameliorates thioacetamide-induced intrahepatic oxidative stress, inflammation and fibrosis in rats. Life Sciences. 286. 120040–120040. 19 indexed citations
11.
Eisa, Nada H., Mohamed El‐Sherbiny, & Nada F. Abo El‐Magd. (2021). Betulin alleviates cisplatin-induced hepatic injury in rats: Targeting apoptosis and Nek7-independent NLRP3 inflammasome pathways. International Immunopharmacology. 99. 107925–107925. 19 indexed citations
12.
El‐Sherbiny, Mohamed, et al.. (2021). Diacerein ameliorates testosterone-induced benign prostatic hyperplasia in rats: Effect on oxidative stress, inflammation and apoptosis. International Immunopharmacology. 100. 108082–108082. 30 indexed citations
13.
El‐Magd, Nada F. Abo, Hasnaa Ali Ebrahim, Mohamed El‐Sherbiny, & Nada H. Eisa. (2021). Quinacrine Ameliorates Cisplatin-Induced Renal Toxicity via Modulation of Sirtuin-1 Pathway. International Journal of Molecular Sciences. 22(19). 10660–10660. 17 indexed citations
14.
Elsherbiny, Nehal M., Nada H. Eisa, Mohamed El‐Sherbiny, & Eman Said. (2020). Chemo-preventive effect of crocin against experimentally-induced hepatocarcinogenesis via regulation of apoptotic and Nrf2 signaling pathways. Environmental Toxicology and Pharmacology. 80. 103494–103494. 19 indexed citations
15.
Eisa, Nada H., Sakamuri V. Reddy, Ahmed M. Elmansi, et al.. (2020). Kynurenine Promotes RANKL-Induced Osteoclastogenesis In Vitro by Activating the Aryl Hydrocarbon Receptor Pathway. International Journal of Molecular Sciences. 21(21). 7931–7931. 38 indexed citations
16.
17.
Elmansi, Ahmed M., Nada H. Eisa, Dmitry Kondrikov, et al.. (2019). KYNURENINE, AN ENDOGENOUS AHR AGONIST, UPREGULATES CXCL12- AND HDAC3-TARGETING MIRNAS INHIBITING OSTEOGENESIS. Innovation in Aging. 3(Supplement_1). S946–S947. 1 indexed citations
18.
Kondrikov, Dmitry, Ahmed M. Elmansi, Thomas F. Barrett, et al.. (2019). Kynurenine inhibits autophagy and promotes senescence in aged bone marrow mesenchymal stem cells through the aryl hydrocarbon receptor pathway. Experimental Gerontology. 130. 110805–110805. 69 indexed citations
19.
Chow, Sharon, Nada H. Eisa, Luke W. Guddat, et al.. (2018). Synthesis of the seco‐Limonoid BCD Ring System Identifies a Hsp90 Chaperon Machinery (p23) Inhibitor. Chemistry - A European Journal. 25(6). 1451–1455. 14 indexed citations
20.
Eisa, Nada H., et al.. (2014). Galectin-3 and matrix metalloproteinase-9: Perspective in management of hepatocellular carcinoma. Journal of Oncology Pharmacy Practice. 21(5). 323–330. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eslam E. Abd El-Fattah Breakdown of academic impact, for papers by Brian K. Park Breakdown of academic impact, for papers by Dejun Cui Breakdown of academic impact, for papers by Yi A. Ren Breakdown of academic impact, for papers by Bo Youn Choi Breakdown of academic impact, for papers by Mahmoud E. Youssef Breakdown of academic impact, for papers by Fanhua Meng Breakdown of academic impact, for papers by Luling He
Rankless by CCL
2026